Shoulder Innovations (SI) Stock Price, News & Analysis

Company Overview

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams. The company collaborates with leading orthopedic specialists to refine surgical techniques, develop new implant geometries and conduct outcome studies. Its research and development efforts focus on advanced materials, biomechanical testing and minimally invasive procedures to improve implant longevity and patient recovery times.

Headquartered in the United States, Shoulder Innovations markets its products through a network of direct sales professionals and distribution partners to hospitals and surgical centers nationwide. The company is led by a management team with extensive experience in medical device development, regulatory affairs and orthopedic innovation. By investing in strategic partnerships and continuing education initiatives, Shoulder Innovations aims to drive growth and advance standards of care in shoulder reconstruction.

Key Stats

• Today's Range: $12.60 to $13.55
• 50-Day Range: $12.35 to $15.23
• 52-Week Range: $10.92 to $17.94
• Volume: 67,472 shs
• Average Volume: 76,517 shs
• Market Capitalization: $268.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $20.80
• Consensus Rating: Moderate Buy

Shoulder Innovations Stock Analysis - MarketRank™

Shoulder Innovations scored higher than 64% of companies evaluated by MarketBeat, and ranked 285th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Shoulder Innovations has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Shoulder Innovations has a consensus price target of $20.80, representing about 60.6% upside from its current price of $12.95.

Amount of Analyst Coverage

Shoulder Innovations has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Shoulder Innovations are expected to decrease in the coming year, from ($1.71) to ($1.73) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Shoulder Innovations is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Shoulder Innovations is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Shoulder Innovations has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.35% of the float of Shoulder Innovations has been sold short.

Short Interest Ratio / Days to Cover

Shoulder Innovations has a short interest ratio ("days to cover") of 5.52.

Change versus previous month

Short interest in Shoulder Innovations has recently increased by 21.57%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Shoulder Innovations does not currently pay a dividend.

Dividend Growth

Shoulder Innovations does not have a long track record of dividend growth.

News and Social Media

• Score: 4.2 / 5
• News Sentiment: 1.65

News Sentiment

Shoulder Innovations has a news sentiment score of 1.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Shoulder Innovations this week, compared to 1 article on an average week.

MarketBeat Follows

2 people have added Shoulder Innovations to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

3 insiders have purchased shares of Shoulder Innovations in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $78,236.00 in company stock, which represents 0.0291% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Shoulder Innovations insiders have bought more of their company's stock than they have sold. Specifically, they have bought $78,236.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.71% of the stock of Shoulder Innovations is held by insiders.

Percentage Held by Institutions

Shoulder Innovations has minimal institutional ownership at this time.

SI Stock Analysis - Frequently Asked Questions

How have SI shares performed this year?

Shoulder Innovations' stock was trading at $14.28 on January 1st, 2026. Since then, SI shares have decreased by 9.3% and is now trading at $12.9490.

How were Shoulder Innovations' earnings last quarter?

Shoulder Innovations, Inc. (NYSE:SI) issued its earnings results on Tuesday, March, 10th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.42) by $0.04. The business earned $14.42 million during the quarter, compared to the consensus estimate of $12.69 million. Shoulder Innovations had a negative net margin of 85.29% and a negative trailing twelve-month return on equity of 37.68%.
Read the conference call transcript.

Does Shoulder Innovations have any subsidiaries?

Shoulder Innovations subsidiaries include Silvergate Bank, Silvergate Capital Trust I, Silvergate Capital Trust II, and Spring Valley Lots.

When did Shoulder Innovations IPO?

Shoulder Innovations (SI) raised $100 million in an initial public offering on Thursday, July 31st 2025. The company issued 5,000,000 shares at $19.00-$21.00 per share.

Who are Shoulder Innovations' major shareholders?

Top institutional investors of Shoulder Innovations include Bank of New York Mellon Corp (0.08%) and Blue Trust Inc. (0.08%). Insiders that own company stock include Geoffrey B Pardo, Healthcare Holding BV Gilde, Lsv Associates Ii, Llc, Michael A Carusi, Robert Joseph Ball and Jeffrey S Points.
View institutional ownership trends.

How do I buy shares of Shoulder Innovations?

Shares of SI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Shoulder Innovations own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Shoulder Innovations investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), PayPal (PYPL), Alibaba Group (BABA).

Company Calendar

• Last Earnings: 3/10/2026
• Today: 5/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:SI
• Previous Symbol: NYSE:SI
• CIK: 1699350
• Web: N/A
• Phone: 616-566-0286
• Fax: N/A
• Employees: 61
• Year Founded: 2015

Price Target and Rating

• Average Price Target for Shoulder Innovations: $20.80
• High Price Target: $24.00
• Low Price Target: $18.00
• Potential Upside/Downside: +60.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($218.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$40.36 million
• Net Margins: -85.29%
• Pretax Margin: -85.29%
• Return on Equity: -37.68%
• Return on Assets: -18.63%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 11.07
• Quick Ratio: 9.55

Sales & Book Value

• Annual Sales: $47.32 million
• Price / Sales: 5.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.83 per share
• Price / Book: 1.90

Miscellaneous

• Outstanding Shares: 20,728,000
• Free Float: N/A
• Market Cap: $268.41 million
• Optionable: No Data
• Beta: N/A